Quantum-Si Reports Second Quarter 2023 Financial Results

BRANFORD, Conn.–(BUSINESS WIRE)–Aug. 7, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the second quarter ended June 30, 2023. Second Quarter Highlights Recognized revenue of $205,000 in the second quarter of 2023. Exited the quarter with an order backlog of two Platinum™ instruments. Strengthened […]

Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference

BRANFORD, Conn.–(BUSINESS WIRE)–Jul. 26, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Canaccord Genuity 43rd Annual Growth Conference taking place at the InterContinental Boston Hotel on August 7-10, 2023. Jeff Hawkins, Quantum-Si’s Chief Executive Officer, will participate in the panel […]

Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023

BRANFORD, Conn.–(BUSINESS WIRE)–Jul. 18, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will report financial results for the second quarter 2023 on Monday, August 7, 2023. Company management will host a conference call to discuss financial results and provide a business update on the same […]

Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations

BRANFORD, Conn.–(BUSINESS WIRE)–Jun. 21, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Johan Denecke as Senior Vice President of Operations, effective June 20, 2023. Mr. Denecke will be responsible for scaling up production and driving operational and quality excellence in support of the commercialization […]

Quantum-Si to Participate in the Jefferies Healthcare Conference

BRANFORD, Conn.–(BUSINESS WIRE)–May 25, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced that it will be participating in the Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY on June 7-9, 2023. Quantum-Si’s management will present on Thursday, June 8, 2023 at 8:30 AM […]

Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors

GUILFORD, Conn.–(BUSINESS WIRE)–May 22, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jack Kenny, CEO of Meridian Bioscience, Inc., to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230522005246/en/ (Photo: Business Wire) “Jack brings a wealth of experience […]

Scott Mendel Elected to Quantum-Si Board of Directors

GUILFORD, Conn.–(BUSINESS WIRE)–May 15, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the election of Scott Mendel, former President and Chief Executive Officer of GenMark Diagnostics, Inc., to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230515005191/en/ Scott Mendel Elected to […]

Quantum-Si Reports First Quarter 2023 Financial Results

Q1 2023 revenue $254,000 on orders of $449,000; gross margin 48.8% This was the Company’s first quarter of revenue generated on the sale of PlatinumTM instruments and kits Expect revenue to accelerate in the second half of 2023 based on robust business funnel GUILFORD, Conn.–(BUSINESS WIRE)–May 11, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or […]

Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer

Appointment positions company for strategic growth in next-generation protein sequencing GUILFORD, Conn.–(BUSINESS WIRE)–May 2, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer, effective May 15, 2023. Mr. Keyes brings more than 25 years of experience in senior […]

Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments

Quantum-Si Strengthens Commercial, Operations, and Development Teams to Accelerate the Commercial Advancement of the Platinum™ Protein Sequencing Platform GUILFORD, Conn.–(BUSINESS WIRE)–Apr. 24, 2023– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointments of Katherine Atkinson as Senior Vice President of Demand Generation and Corporate Brand, Alex Hutcheson […]